Selecta Biosciences Announces CEO’s Intent to Retire and Transition Plan
Dr. Werner Cautreels Plans Retirement at the End of 2018 Dr. Omid Farokhzad Appointed Chairman of the Board WATERTOWN, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage biopharmaceutical company focused on …